Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics

The rapid growth of COVID-19 cases is causing an increasing death toll and also paralyzing the world economy. De novo drug discovery takes years to move from idea and/or pre-clinic to market, and it is not a short-term solution for the current SARS-CoV-2 pandemic. Drug repurposing is perhaps the onl...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:RSC Med Chem
Egile Nagusiak: Oerlemans, Rick, Ruiz-Moreno, Angel Jonathan, Cong, Yingying, Dinesh Kumar, Nilima, Velasco-Velazquez, Marco A., Neochoritis, Constantinos G., Smith, Jolanda, Reggiori, Fulvio, Groves, Matthew R., Dömling, Alexander
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: RSC 2020
Gaiak:
Chemistry
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8130630/
https://ncbi.nlm.nih.gov/pubmed/34041486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0md00367k
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak